Coldstream Capital Management Inc Horizon Therapeutics Public LTD CO Transaction History

Coldstream Capital Management Inc

  • $4.58 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 10, 2023
BUY
$62.39 - $113.8 $120,911 - $220,544
1,938 New
1,938 $0
Q1 2022

May 11, 2022
SELL
$86.42 - $109.81 $196,346 - $249,488
-2,272 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$98.56 - $119.91 $223,928 - $272,435
2,272 New
2,272 $245,000
Q3 2021

Nov 12, 2021
SELL
$91.91 - $110.37 $195,676 - $234,977
-2,129 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$86.24 - $95.92 $183,604 - $204,213
2,129 New
2,129 $200,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email